Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19

Our main aim was to describe the effect on the severity of ACEI (angiotensin-converting enzyme inhibitor) and ARB (angiotensin II receptor blocker) during COVID-19 hospitalization. A retrospective, observational, multicenter study evaluating hospitalized patients with COVID-19 treated with ACEI/ARB....

Descripción completa

Detalles Bibliográficos
Autores principales: Roy-Vallejo, Emilia, Sánchez Purificación, Aquilino, Torres Peña, José David, Sánchez Moreno, Beatriz, Arnalich, Francisco, García Blanco, María José, López Miranda, José, Romero-Cabrera, Juan Luis, Herrero Gil, Carmen Rosario, Bascunana, José, Rubio-Rivas, Manuel, Pintos Otero, Sara, Martínez Sempere, Verónica, Ballano Rodríguez-Solís, Jesús, Gil Sánchez, Ricardo, Luque del Pino, Jairo, González Noya, Amara, Navas-Alcántara, María Sierra, Cortés Rodríguez, Begoña, Alcalá, José Nicolás, Suárez-Lombraña, Ana, Andrés Soler, Jorge, Gómez-Huelgas, Ricardo, Casas-Rojo, José Manuel, Millán Núñez-Cortés, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232748/
https://www.ncbi.nlm.nih.gov/pubmed/34204014
http://dx.doi.org/10.3390/jcm10122642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232748/
https://www.ncbi.nlm.nih.gov/pubmed/34204014
http://dx.doi.org/10.3390/jcm10122642

Ejemplares similares